Dr. Theresa Tam, Canada’s chief public officer of health, explained the process Public Health goes through when changing guidance on the AstraZeneca vaccine given reports of blood clot side effects. Tam said the science and evidence is emerging fast and thus requires a fast approach in evolving the guidance.
- AstraZeneca vaccine trial in kids paused as adult blood clot link investigated
- U.K. regulator reports 30 blood clot cases linked to AstraZeneca COVID-19 vaccine
- Australia to continue using AstraZeneca COVID-19 vaccine despite blood clot case